Table 1.
Class | Consequence of mutation | Mutation-specific therapy |
---|---|---|
I | No CFTR synthesis | Ataluren (PTC124) |
II | Failure of CFTR to traffic to the cell surface | VX-809 and ivacaftor (combination) |
VX-661 and ivacaftor (combination) | ||
III | Failure of CFTR to open at cell surface | Ivacaftor |
IV | Decreased time CFTR channel is open at cell surface | |
V | Decreased amount of CFTR at cell surface | |
VI | Unstable CFTR with decreased half-life at the cell surface |
Abbreviation: CFTR, CF transmembrane conductance regulator.